Target intelligence / Profile preview

X antigen family member 1A (XAGE1A)

Target
XAGE1A
Molecular classification
Cancer-testis antigen, GAGE family protein, Nuclear-localized protein, Other
01

Overview

X antigen family member 1A (XAGE1A) is a member of the GAGE family of cancer-testis (CT) antigens, characterized by expression in various tumors (such as Ewing’s sarcoma, rhabdomyosarcoma, and ovarian carcinoma) and normal testis, but generally not in other normal tissues[1][2][3][5][6]. The protein contains a nuclear localization signal, and alternative splicing produces multiple isoforms. XAGE1A and related CT antigens are involved in normal germ cell biology (spermatogenesis) and may contribute to tumor development and metastatic progression, notably through mechanisms such as apoptosis avoidance and potentially promoting epithelial-to-mesenchymal transition (EMT)[2][4]. High XAGE1A expression serves as a specific biomarker for several cancers—especially ovarian cancer, where it can differentiate malignant from benign lesions and is linked to poor prognosis and advanced stage[2][6]. XAGE1A is being investigated as a candidate for cancer diagnosis and immunotherapy[2][4][6]. No direct information is available for approved drug interactions or specific molecular inhibitors.

Other names
XAGE-1CT12.1Cancer/testis antigen 12.1G antigen family D member 2GAGED2CTP9CT12.1AXAGE1XAGE1BXAGE1CXAGE1Dprotein XAGE-1
02

Biological functions

SpermatogenesisApoptosis avoidanceTumorigenesisMay function as an immunogen in cancer
03

Disease associations

CancerSmall cell carcinomaRhabdomyosarcomaEwing’s sarcomaOvarian cancerOther epithelial malignancies (e.g., breast, prostate, lung, metastatic melanoma)
04

Safety considerations

Specific safety concerns or immunotherapy challenges not described in available sources; as a cancer-testis antigen, possible risk for off-target immune effects on reproductive tissues
05

Biomarkers

Diagnostic biomarker for ovarian cancer and possibly other malignancies (elevated expression discriminates malignant from benign tumors)Potential prognostic marker (high level associated with advanced stage and possibly poor prognosis in ovarian cancer)

Beyond the preview

Go deeper on X antigen family member 1A (XAGE1A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on X antigen family member 1A (XAGE1A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call